These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28869324)

  • 21. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
    Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.
    Neff RT; Hurst FP; Falta EM; Bohen EM; Lentine KL; Dharnidharka VR; Agodoa LY; Jindal RM; Yuan CM; Abbott KC
    Transplantation; 2008 Nov; 86(10):1474-8. PubMed ID: 19034021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Age on Leukopenia Following Renal Transplantation at a Single Center.
    Yang Y; Guerra CM; Sumrani N
    Prog Transplant; 2019 Mar; 29(1):54-60. PubMed ID: 30514165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory ascites induced by mycophenolate in a pediatric kidney transplant patient.
    Kim JY; Jang JH; Cho H
    Clin Nephrol; 2021 Apr; 95(4):215-220. PubMed ID: 33560222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil in pediatric renal transplantation.
    Weber LT; Höcker B; Mehls O; Tönshoff B
    Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.
    Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y
    Transplant Proc; 2004 Sep; 36(7):2068-70. PubMed ID: 15518748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir].
    Izquierdo MJ; Rodrigo E; de Cos MA; Arias M
    Nefrologia; 2007; 27(2):232-3. PubMed ID: 17564576
    [No Abstract]   [Full Text] [Related]  

  • 29. Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients.
    Bouamar R; Hesselink DA; van Schaik RH; Weimar W; van der Heiden IP; de Fijter JW; Kuypers DR; van Gelder T
    Pharmacogenet Genomics; 2012 Jun; 22(6):399-407. PubMed ID: 21878834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
    Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients.
    Renz JF; Lightdale J; Mudge C; Bacchetti P; Watson J; Ascher NL; Emond JC; Rosenthal P; Roberts JP
    Liver Transpl Surg; 1999 Mar; 5(2):136-43. PubMed ID: 10071353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients.
    Massari P; Duro-Garcia V; Girón F; Hernández E; Juárez F; Castro C; Toledo M;
    Transplant Proc; 2005 Mar; 37(2):916-9. PubMed ID: 15848574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-life-threatening leukopenia in a renal transplant recipient with acute overdose of mycophenolate mofetil.
    Wu SW; Chang HR; Lai YR; Lian JD
    Transplant Proc; 2008 Dec; 40(10):3770-1. PubMed ID: 19100486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients.
    Pascual J; Ocaña J; Marcén R; Fernández A; Galeano C; Alarcón MC; Burgos FJ; Villafruela JJ; Ortuño J
    Transplant Proc; 2006 Oct; 38(8):2398-9. PubMed ID: 17097946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.
    Jungraithmayr T; Staskewitz A; Kirste G; Böswald M; Bulla M; Burghard R; Dippell J; Greiner C; Helmchen U; Klare B; Klaus G; Leichter HE; Mihatsch MJ; Michalk DV; Misselwitz J; Plank C; Querfeld U; Weber LT; Wiesel M; Tönshoff B; Zimmerhackl LB;
    Transplantation; 2003 Feb; 75(4):454-61. PubMed ID: 12605109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation.
    Lopau K; Syamken K; Rubenwolf P; Riedmiller H; Wanner C
    Kidney Blood Press Res; 2010; 33(1):52-9. PubMed ID: 20197687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of leukopenia in kidney and pancreas transplant recipients.
    Hartmann EL; Gatesman M; Roskopf-Somerville J; Stratta R; Farney A; Sundberg A
    Clin Transplant; 2008; 22(6):822-8. PubMed ID: 19040562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
    Sollinger HW; Sundberg AK; Leverson G; Voss BJ; Pirsch JD
    Transplantation; 2010 Feb; 89(4):446-51. PubMed ID: 20177347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.